Anbio Biotechnology (NNNN) stock
NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$3.65−0.23 (-5.93%)
Close on Nov 17, 2026Market cap $525.20MP/E 24.8Yield –
Anbio Biotechnology total assets
Total assets on the balance sheet at the end of each period.
Anbio Biotechnology's total assets was $30.24M at Dec 31, 2025. For fiscal 2025 it was $30.24M, up 59.8% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.24M | +59.8% |
| FY2024 | Dec 31, 2024 | $18.92M | +19.7% |
| FY2023 | Dec 31, 2023 | $15.81M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $30.24M | – |
| Q4 FY2024 | Dec 31, 2024 | $18.92M | – |
| Q4 FY2023 | Dec 31, 2023 | $15.81M | – |
See a number that looks wrong?